ATE539066T1 - Organoselenhaltige verbindungen und deren verwendung - Google Patents

Organoselenhaltige verbindungen und deren verwendung

Info

Publication number
ATE539066T1
ATE539066T1 AT05822319T AT05822319T ATE539066T1 AT E539066 T1 ATE539066 T1 AT E539066T1 AT 05822319 T AT05822319 T AT 05822319T AT 05822319 T AT05822319 T AT 05822319T AT E539066 T1 ATE539066 T1 AT E539066T1
Authority
AT
Austria
Prior art keywords
organosels
compounds containing
compound
present
organoselenium
Prior art date
Application number
AT05822319T
Other languages
German (de)
English (en)
Inventor
Jungyeob Ham
Jaeyoung Ko
Hoosang Hwang
Original Assignee
Seoul Nat Univ Ind Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seoul Nat Univ Ind Foundation filed Critical Seoul Nat Univ Ind Foundation
Priority claimed from PCT/KR2005/004685 external-priority patent/WO2006071103A1/en
Application granted granted Critical
Publication of ATE539066T1 publication Critical patent/ATE539066T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05822319T 2004-12-31 2005-12-30 Organoselenhaltige verbindungen und deren verwendung ATE539066T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20040118109 2004-12-31
PCT/KR2005/004685 WO2006071103A1 (en) 2004-12-31 2005-12-30 Organoselenium containing compounds and their use
KR1020050135761A KR100753860B1 (ko) 2004-12-31 2005-12-30 유기 셀레늄 함유 화합물 및 이들 화합물의 용도

Publications (1)

Publication Number Publication Date
ATE539066T1 true ATE539066T1 (de) 2012-01-15

Family

ID=37170880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05822319T ATE539066T1 (de) 2004-12-31 2005-12-30 Organoselenhaltige verbindungen und deren verwendung

Country Status (4)

Country Link
KR (1) KR100753860B1 (es)
CN (1) CN101146783B (es)
AT (1) ATE539066T1 (es)
ES (1) ES2379800T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012030165A2 (ko) * 2010-08-31 2012-03-08 서울대학교산학협력단 P P A R δ 활성물질의 태자재프로그래밍용도
WO2014050273A1 (ja) * 2012-09-28 2014-04-03 住友精化株式会社 セレノール類の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4345230B2 (ja) * 1998-03-10 2009-10-14 小野薬品工業株式会社 カルボン酸誘導体およびその誘導体を有効成分として含有する薬剤
GB9914977D0 (en) * 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
KR100474202B1 (ko) * 2002-05-04 2005-03-08 강헌중 티아졸 유도체의 제조방법 및 이를 제조하기 위한 중간체
KR100691375B1 (ko) * 2004-02-03 2007-03-09 재단법인서울대학교산학협력재단 페록시솜 증식자 활성화 수용체 델타 리간드의 제조방법 및 이를 제조하기 위한 중간체

Also Published As

Publication number Publication date
ES2379800T3 (es) 2012-05-03
CN101146783B (zh) 2011-02-02
CN101146783A (zh) 2008-03-19
KR100753860B1 (ko) 2007-08-31
KR20060079134A (ko) 2006-07-05

Similar Documents

Publication Publication Date Title
NO20063517L (no) Ny krystallinsk form v av agomelatin, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
MX2007011009A (es) Compuestos de piperidina 3,4,5-substituidos.
NO20060947L (no) β d-krystalinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
TW200738698A (en) Organic compounds
NO20064596L (no) Delta-krystallinsk form av ivabradin-hydroklorid, fremgangsmate for dens fremstilling og farmasoytiske sammensetninger inneholdende den
GEP20115359B (en) Fused cyclic compounds
BRPI0414581C1 (pt) composto, composição farmacêutica compreendendo o referido composto e uso do referido composto
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
MX2008000255A (es) Activadores de urea glucocinasa.
UA86595C2 (ru) Гамма-кристаллическая форма гидрохлорида ивабрадина, способ ее получения и фармацевтическая композиция, которая ее содержит
MX2010005997A (es) Derivados de aminobenzamida como agentes utiles para el control de parasitos de animales.
SI1843754T1 (sl) Novi farmacevtski sestavek, ki vsebuje kandesartan cileksetil kot lipofilno kristalinično snov
DE602005014341D1 (de) Benzimidazolsubstituierte thiophenderivate, die auf ikk3 wirken
BRPI0519443A2 (pt) composto orgÂnicos
TW200626158A (en) Naphthaline derivatives
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
SE0301701D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0402635D0 (sv) Chemical compounds
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200634002A (en) Chemical compounds
AR056369A1 (es) Compuestos derivados de quinazolina y composicion farmaceutica
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
ATE539066T1 (de) Organoselenhaltige verbindungen und deren verwendung
BR0311970A (pt) Novos compostos, seu uso e preparação